
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Lidocaine
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Recipient : Boston Children's Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Lidocaine is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 14, 2017
Lead Product(s) : Lidocaine
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Recipient : Boston Children's Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
